Design Therapeutics (DSGN) News Today

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

$3.70

-0.04 (-1.07%)

(As of 04/19/2024 ET)

Source

Source	Headline
	Design Therapeutics, Inc. (NASDAQ:DSGN) Receives Consensus Rating of "Hold" from Analysts americanbankingnews.com - April 14 at 4:08 AM
	Design Therapeutics, Inc. (NASDAQ:DSGN) Receives Consensus Recommendation of "Hold" from Analysts marketbeat.com - April 14 at 4:07 AM
	Design Therapeutics, Inc. (NASDAQ:DSGN) Short Interest Update marketbeat.com - March 31 at 12:40 AM
	Independent Director of Design Therapeutics Picks Up 88% More Stock finance.yahoo.com - March 27 at 10:27 AM
	Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying msn.com - March 26 at 10:53 AM
	Design Therapeutics, Inc. (NASDAQ:DSGN) Director John P. Schmid Purchases 9,156 Shares insidertrades.com - March 26 at 5:34 AM
	Design Therapeutics, Inc. (NASDAQ:DSGN) Director Purchases $66,605.66 in Stock insidertrades.com - March 26 at 4:44 AM
	John P. Schmid Acquires 9,156 Shares of Design Therapeutics, Inc. (NASDAQ:DSGN) Stock marketbeat.com - March 25 at 9:33 PM
	Design Therapeutics, Inc. to Post FY2026 Earnings of ($1.27) Per Share, Wedbush Forecasts (NASDAQ:DSGN) marketbeat.com - March 22 at 8:39 AM
	RBC Capital Reaffirms Their Hold Rating on Design Therapeutics (DSGN) markets.businessinsider.com - March 21 at 6:29 PM
	Hold Rating Maintained for Design Therapeutics Amid Drug Reformulation and Program Updates markets.businessinsider.com - March 21 at 6:29 PM
	Leerink Partnrs Comments on Design Therapeutics, Inc.'s FY2025 Earnings (NASDAQ:DSGN) marketbeat.com - March 21 at 8:36 AM
	Design Therapeutics Outlines Progress Across GeneTAC(TM) Platform and Announces Fourth Quarter and Full Year 2023 Financial Results stockhouse.com - March 20 at 10:41 PM
	Design Therapeutics (NASDAQ:DSGN) Receives Sector Perform Rating from Royal Bank of Canada marketbeat.com - March 20 at 11:20 AM
	Design Therapeutics, Inc. (NASDAQ:DSGN) Receives Consensus Rating of "Hold" from Brokerages marketbeat.com - March 20 at 11:19 AM
	DSGN Stock Earnings: Design Therapeutics Beats EPS for Q4 2023 investorplace.com - March 19 at 10:01 PM
	Design Therapeutics Inc (DSGN) Reports Full Year 2023 Financial Results and Pipeline Progress finance.yahoo.com - March 19 at 7:35 PM
	Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results globenewswire.com - March 19 at 4:01 PM
	Design Therapeutics Inc (DSGN) investing.com - March 18 at 6:32 PM
	Earnings Preview For Design Therapeutics benzinga.com - March 18 at 1:28 PM
	DSGN Apr 2024 7.500 put finance.yahoo.com - March 15 at 9:33 PM
	DSGN Jul 2024 2.500 put finance.yahoo.com - March 15 at 9:33 PM
	Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update globenewswire.com - March 12 at 6:30 AM
	Design Therapeutics (DSGN) Set to Announce Earnings on Tuesday marketbeat.com - March 11 at 7:39 AM
	RTW Investments LP Boosts Stock Position in Design Therapeutics, Inc. (NASDAQ:DSGN) marketbeat.com - March 6 at 11:01 AM
	SR ONE CAPITAL PARTNERS I, LP's Net Worth benzinga.com - February 9 at 4:07 PM
	Design Therapeutics, Inc. (NASDAQ:DSGN) Receives Average Recommendation of "Hold" from Analysts marketbeat.com - February 7 at 2:30 AM
	Short Interest in Design Therapeutics, Inc. (NASDAQ:DSGN) Grows By 9.7% marketbeat.com - January 15 at 7:36 AM
	Design Therapeutics, Inc. (NASDAQ:DSGN) Given Average Rating of "Hold" by Analysts marketbeat.com - January 13 at 2:22 AM
	Short Interest in Design Therapeutics, Inc. (NASDAQ:DSGN) Declines By 19.2% marketbeat.com - January 1 at 12:20 AM
	Design Therapeutics, Inc. (NASDAQ:DSGN) Given Average Recommendation of "Hold" by Analysts marketbeat.com - December 19 at 2:43 AM
	Design Therapeutics, Inc. (DSGN) Upgraded to Buy: Here's What You Should Know finance.yahoo.com - December 18 at 2:25 PM
	Design Therapeutics Inc DSGN morningstar.com - December 7 at 10:52 PM
	Positive Signs As Multiple Insiders Buy Design Therapeutics Stock finance.yahoo.com - November 25 at 9:18 AM
	Hold Rating on Design Therapeutics Amid Mixed Efficacy Data, Strategic Realignment and Financial Uncertainties markets.businessinsider.com - November 16 at 11:57 PM
	Design Therapeutics Inc (DSGN) Reports Q3 2023 Financials, Plans Strategic Update finance.yahoo.com - November 14 at 9:46 PM
	Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024 finance.yahoo.com - November 13 at 8:23 PM
	Short Interest in Design Therapeutics, Inc. (NASDAQ:DSGN) Drops By 42.2% marketbeat.com - September 15 at 8:26 AM
	Avoro Capital Advisors LLC Raises Stock Position in Design Therapeutics, Inc. (NASDAQ:DSGN) marketbeat.com - September 12 at 5:49 AM
	Design Therapeutics (NASDAQ: DSGN) fool.com - September 8 at 3:45 PM
	Director At This Health Care Company Buys $14.00M of Stock benzinga.com - September 7 at 2:42 PM
	ExodusPoint Capital Management LP Acquires 105,407 Shares of Design Therapeutics, Inc. (NASDAQ:DSGN) marketbeat.com - September 6 at 5:00 AM
	Why Shares of Design Therapeutics Are Plummeting on Tuesday finance.yahoo.com - August 23 at 1:31 AM
	Why Is Design Therapeutics Stock Moving Lower Today? markets.businessinsider.com - August 16 at 5:26 PM
	Wedbush cuts Design Therapeutics to neutral, cites ataxia drug setback msn.com - August 15 at 5:37 PM
	Multiple Downgrades Send Design Therapeutics (NASDAQ:DSGN) Down in Flames msn.com - August 15 at 5:37 PM
	RBC Capital cuts Design Therapeutics to sector perform, cites limited catalysts msn.com - August 15 at 5:37 PM
	Design Therapeutics' Modified DT-216 May Have Potential, But Analyst Awaits Further Developments markets.businessinsider.com - August 15 at 5:37 PM
	Design Therapeutics stock plunges on trial results for neuromuscular disease treatment msn.com - August 15 at 8:28 AM
	Design Therapeutics Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich Ataxia finance.yahoo.com - August 14 at 5:27 PM

Get Design Therapeutics News Delivered to You Automatically

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

DSGN Media Mentions By Week

DSGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DSGN
News Sentiment
▼
0.67

0.52
▲
Average
Medical
News Sentiment

DSGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DSGN Articles
This Week
▼
2

1
▲
DSGN Articles
Average Week

Get Design Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:DSGN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Design Therapeutics (DSGN) News Today

DSGN Media Mentions By Week

DSGN Media Sentiment

DSGN News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info